News
GSK has agreed to pay $1.2 billion upfront to acquire rights to efimosfermin from Cambridge, Massachusetts-based Boston ...
The drive revolves around a "10-for-one" policy laid out in a Trump executive order at the end of January, which demanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback